Another electric Jeep SUV is almost here. With its official debut just around the corner, Jeep’s new Recon EV was spotted charging in production form, giving us our best look at the Wrangler ...
Vande Bharat Sleeper train updates: The first prototype of Vande Bharat Sleeper train underwent a trial run. According to the media reports, the semi-high-speed train completed a trial run between ...
The popular anime MF Ghost has been confirmed for a third season, continuing the high-octane journey of Kanata Rivington. Along with the announcement, a teaser trailer and visual have been ...
But perhaps its biggest yet—a scaled replica of Star Wars Rebels‘ main ship, the Ghost—is starting to ship out to backers, giving them what might be the closest we have to an ultimate action ...
The “four-piper” destroyer ship was the only vessel captured by Japanese forces during World War II, and earned its “Ghost Ship” moniker after numerous Allied troops sighted it deep behind ...
The failure of two of the biggest chip companies in the world to reach a settlement before the case reached trial had surprised analysts. “It is clear that Qualcomm came out on top,” said ...
"I was always very disappointed if there wasn't a ghost or a monster," he says. Gatiss, an actor and writer perhaps best known for co-creating BBC series such as Sherlock and Dracula, remembers ...
The limited-time trial includes all platforms and marks the midpoint of Season 6. For prospective buyers, Diablo 4 is currently on sale for up to 40% off. Path of Exile 2 and Diablo 4 share a lot ...
By Isabella Kwai A trial in Romania for Andrew Tate, the online influencer who is facing criminal accusations involving human trafficking and sexual misconduct, will not go ahead, at least for now ...
Blizzard is running a free Diablo 4 trial for the holidays, where you can play the full RPG and even get access to its busted Spiritborn class for a short while. Diablo 4’s free trial is live ...
CagriSema helped patients lose an average of 22.7 per cent of their body weight in a late-stage trial, Novo Nordisk said on Friday, only marginally beating the results of Mounjaro, a rival ...